Female Subfertility & Gynecological Endocrinology Evaluations
To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.
Sign in | Free Trial | Subscribe | Recommend to Library
New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.
Section Topics
- » Adrenal function & dysfunction
- » Assisted reproductive technology (ART): clinical research
- » Assisted reproductive technology (ART): embryology
- » Endocrinological abnormalities in the pediatric/adolescent patient
- » Endometrial function & dysfunction
- » Ethical aspects of infertility treatment
- » General non-ART female infertility
- » Hypothalamic-pituitary-ovarian disorders
- » Oocyte function & reproductive aging
- » Ovulatory dysfunction
- » Physiology of the menstrual cycle
- » Polycystic ovary syndrome
- » Primary ovarian failure
- » Reproductive failure
- » Surgical infertility
LATEST EVALUATION
Lois Salamonsen, Prince Henry's Institute of Medical Research, Australia. F1000 Women's Health
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Evaluation, most recent by
Mauricio Abrao, Luiz Fernando de Oliveira Henrique and Joao Dias Jr, University of São Paulo Medical School, Brazil. F1000 Women's Health
- Confirmation
INDIVIDUALS
Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.
Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.
RECOMMENDATIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
LIBRARIANS & INFORMATION MANAGERS
Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.
FREE ACCESS
Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
